This paper reviews recent literature on the psychopharmacologic management of borderline personality disorder (BPD) patients and discusses an approach to drug therapy. Five randomized controlled trials have shown positive, but non-specific effects of antipsychotic drugs on the symptoms suffered by BPD patients. There were too few data on other types of drugs to draw any conclusion. We propose that BPD patients be treated on the basis of being in a state or episode of co-existing Axis I disorder.
References
1.
DyrudJEThe treatment of the borderline syndrome. In: OfferE, FreedmanDX eds. Modern psychiatry and clinical research.New York: Basic Books,1972: 159–173.
2.
VilkinMIComparative chemotherapeutic trial in treatment of chronic borderline patients.Am J Psychiatry1964; 120: 1004.
3.
SpitzerRL, WilliamsJ.B.W.Hysteroid dysphoria: an unsuccessful attempt to demonstrate its syndromal validity.Am J Psychiatry1982; 139: 1286–1291.
4.
BrinkleyJR, BeitmanBD, FriedelROLow dose neuroleptic regimes in the treatment of borderline patients.Arch Gen Psychiatry1979; 36: 319–326.
5.
BonnetKA, RedfordHRLevodopa in borderline disorders.Arch Gen Psychiatry1982; 39: 862.
6.
FaltusFJThe positive effect of alprazolam in the treatment of three patients with borderline personality disorder.Am J Psychiatry1984; 141: 802–803.
7.
GarbuttJC, LoosenPTA dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.Psychoneuroendocrinology1984; 9: 311–314.
8.
HoobermanD, SternTATreatment of attention deficit and borderline personality disorders with psychostimulants: case report.J Clin Psychiatry1984; 45: 441–442.
9.
PerseT, GreistJHSelf-destructive behavior in a patient taking trazodone.Am J Psychiatry,1984; 141: 1646–1647.
10.
SoloffPHPharmacotherapy of borderline disorders.Compr Psychiatry1981; 22: 535–543.
SerbanG, SiegelSResponse of borderline and schizotypal patients to small doses of thiothixene and haloperidol.Am J Psychiatry1984; 141: 1455–1458.
13.
LeoneNFResponse of borderline patients to loxapine and chlorpromazine.J Clin Psychiatry1982; 43: 148–150.
14.
ReusVI, MarkrowSAlprazolam in the treatment of borderline personality disorder. Presented at the Annual Meeting of the Society of Biological Psychiatry, 1984. Abstract No. 143.
15.
GardnerDL, CowdryRWSuicidal and parasuicidal behavior in borderline personality disorder.Psychiatr Clin North Amer1985; 8: 389–403.
GardnerDL, CowdryRWPositive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.Am J Psychiatry1986; 143: 519–522.
18.
SoloffPH, GeorgeA, NathanRS, SchulzPM, UlrichRF, PerelJMProgress in pharmacotherapy of borderline disorders.Arch Gen Psychiatry1986; 43: 691–697.
19.
GoldbergSC, SchulzSC, SchulzPM, ResnickRJ, HamerRM, FriedelROBorderline and schizotypal personality disorders treated with low-dose thiothixene versus placebo.Arch Gen Psychiatry1986; 43: 680–686.
20.
SoloffPH, GeorgeA, NathanRS, SchulzPM, UlrichRF, PerelJMAmitriptyline and haloperidol in unstable and schizotypal borderline disorders.Psychopharmacol Bull1986; 22: 177–182.
21.
SoloffPH, GeorgeA, NathanRS, SchulzPM, PerelJMParadoxical effects of amitriptyline on borderline patients.Am J Psychiatry1986; 143: 1603–1605.
22.
GardnerDL, CowdryRWDevelopment of melancholia during carbamazepine treatment in borderline personality disorder.J Clin Psychopharmacol1986; 6: 236–239.
